A Comparison of Naropin and Ketorolac for Postoperative Analgesia After Total Knee Arthroplasty
Local Infiltration Analgesia for Total Knee Arthroplasty: Should Ketorolac be Added
1 other identifier
interventional
60
1 country
1
Brief Summary
The purpose of this study is to determine wether ketorolac is effective in the treatment of postoperative pain after total knee arthroplasty
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4 postoperative-pain
Started May 2009
Typical duration for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2009
CompletedFirst Posted
Study publicly available on registry
March 25, 2009
CompletedStudy Start
First participant enrolled
May 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedResults Posted
Study results publicly available
March 10, 2014
CompletedMarch 10, 2014
July 1, 2013
2.1 years
March 24, 2009
July 10, 2013
January 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Morphine Consumption
Consumption of intravenous (i.v.) patient-controlled analgesia (PCA) morphine during the first forty-eight hours after surgery
48 hours after surgery
Secondary Outcomes (5)
Time to First i.v. Patient Controlled Analgesia (PCA) Morphine Request
within 48 hours after surgery
Pain Intensity Scores During Walking
6-24 hours postoperatively
Home Readiness
time to fulfilment of discharge criteria
Length of Hospital Stay
From the day of surgery until discharge
Pain Intensity During Daily Activity
16 weeks after surgery
Study Arms (2)
Saline
PLACEBO COMPARATORKetorolac
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Total knee arthroplasty
- Age \> 18
- Tolerance for study drugs
- Written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University
Aarhus, 8000, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Karen V Andersen
- Organization
- Aarhus University Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Kjels Søballe, Professor
Aarhus University Hospital
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2009
First Posted
March 25, 2009
Study Start
May 1, 2009
Primary Completion
June 1, 2011
Study Completion
September 1, 2011
Last Updated
March 10, 2014
Results First Posted
March 10, 2014
Record last verified: 2013-07